The effect of oral contraceptives on antiaggregatory prostacyclin and proaggregatory thromboxane A2 in humans
- 1 March 1982
- journal article
- research article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 142 (5), 573-576
- https://doi.org/10.1016/0002-9378(82)90764-5
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Effect of synthetic estrogen on platelet aggregation and vascular release of PGI2-like material in the rabbitProstaglandins, 1980
- Prostacyclin-Like Activity in the Female Rat Thoracic Aorta and the Inferior Vena Cava after Ethinyloestradiol and NorethisteroneClinical Science, 1980
- Measurement of thromboxane B2 in human plasma or serum by radioimmunoassayProstaglandins, 1980
- Enhanced prostacyclin formation in veins of women under chronical treatment with oral contraceptive drugsPharmacological Research Communications, 1980
- Progestogens and cardiovascular reactions associated with oral contraceptives and a comparison of the safety of 50- and 30-microgram oestrogen preparations.BMJ, 1980
- ORAL CONTRACEPTIVES AND THROMBOEMBOLIC DISEASE: EFFECTS OF LOWERING ŒSTROGEN CONTENTThe Lancet, 1980
- Arachidonic Acid Metabolites and the Interactions between Platelets and Blood-Vessel WallsNew England Journal of Medicine, 1979
- Increased prostacyclin-like activity in vascular tissues from rats on long-term treatment with an destrogen-progestagen combinationThrombosis Research, 1979
- The chemical structure of prostaglandin X (prostacyclin)Prostaglandins, 1976
- An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregationNature, 1976